Among the others, the activation of the 5-hydroxytryptamine receptor 1A (5-HT1A) is considered as one of the main mechanisms underlying the neuroprotective effects of CBD in neurological diseases [7,8,9]. This evidence concerns the gene HTR1A and nervous system disorder.